Trisol Medical, a portfolio company of the Alon MedTech Ventures, which is developing an innovative heart valve implanted by catheterization, has completed a $2.7 financing round from US, Israeli, and Chinese investors.
The company recently graduated from the incubator, owned and managed by Dr. Shimon Eckhouse, an active investor in medical devices companies. Trisol develops a Transcatheter Tricuspid Valve Replacement (TTVR). The Trisol valve is constructed out of nitinol frame with specially designed sail-like leaflet. Its unique design provides a comprehensive solution to Tricuspid Regurgitation and RV dysfunction.